HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

Histamine

HCID 774
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
51-45-6
Standard SMILES
NCCc1cnc[nH]1
InChIKey
NTYJJOPFIAHURM-UHFFFAOYSA-N
Molecular formula
C5H9N3
Average molar mass
111.15 g/mol
Monoisotopic mass
111.07964729

Overview

Histamine is a member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group. It has a role as a neurotransmitter, a mouse metabolite and a human metabolite. It is a member of imidazoles and an aralkylamino compound. It is a conjugate base of a histaminium.

Names & identifiers

Preferred name
Histamine
IUPAC
2-(1H-imidazol-5-yl)ethanamine
English name
Histamine
Molecular formula
C5H9N3
Molecular weight
111.15

Names & synonyms

histamine51-45-62-(1H-imidazol-5-yl)ethanamineErgamineErgotidine1H-Imidazole-4-ethanamine2-(4-Imidazolyl)ethylamine5-ImidazoleethylamineEraminTheramineFree histaminebeta-Aminoethylglyoxaline
Show more names
2-(1H-Imidazol-4-yl)ethan-1-amineHISTAMIN2-(1H-Imidazol-4-yl)ethanamine2-(1H-iMidazol-5-yl)ethan-1-aMineEramineistaminaHIS ELISA
beta-Aminoethylimidazole4-(2-Aminoethyl)-1H-imidazole4-ImidazoleethylamineImidazole-4-ethylaminebeta-Imidazolyl-4-ethylamineImidazole, 4-(2-aminoethyl)-DTXSID4023125CHEBI:18295

Database identifiers

CAS
51-45-6
PubChem CID
774
DTXSID
DTXSID4023125
ChEMBL
CHEMBL90
ChEBI
CHEBI:18295
UNII
820484N8I3
EC Number
200-100-6
Nikkaji
J4.117C

Properties

Computed structural properties

XLogP
-0.7
Topological polar surface area
54.7 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
2
Heavy atoms
8
Formal charge
0
Complexity
64.7

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceutical

Pharmaceuticals -> Listed in ZINC15

LogP · 2 items

-0.70

-0.7

Color/FormNEEDLES FROM CHLOROFORM
Solubility · 3 items

COLORLESS LONG PRISMATIC CRYSTALS; ODORLESS; 1 G SOL IN ABOUT 4 ML WATER; AQ SOLN IS ACID TO LITMUS; WHEN DRIED AT 105 °C FOR 2 HR, IT MELTS AT ABOUT 140 °C /PHOSPHATE/

FREELY SOL IN WATER, ALCOHOL, HOT CHLOROFORM; SPARINGLY SOL IN ETHER

14.1 [ug/mL] (The mean of the results at pH 7.4)

Boiling Point209-210 °C @ 18 MM HG
Melting Point · 2 items

83-84 °C

86 °C

Physical DescriptionSolid
Stability/Shelf LifeSTABLE IN AIR BUT IS AFFECTED BY LIGHT /PHOSPHATE/
Dissociation Constants · 2 items

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 6.7% (3 of 45) of reports.

Danger

H301 (93.3%): Toxic if swallowed [Danger Acute toxicity, oral]

P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 45 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (93.3%)

Toxicology

Interactions · 2 items

INHIBITORY EFFECT OF METHAMIDE (POTENT H2 ANTAGONIST) ON GASTRIC ACID SECRETION ELICITED BY CONTINUOUS HISTAMINE IV INFUSION IN MAX EFFECTIVE DOSE (20 UMOLE/HR) IN DOGS IS SHOWN TO BE APPROX 20%/10 UMOLE/KG AFTER 1.5 HR. COMPARABLE EFFECTS WERE OBSERVED IN NORMAL HUMANS IN SAME STUDY. /H2-RECEPTOR ANTAGONISTS, FROM TABLE/

IN GUINEA PIGS, DEATH BY ASPHYXIA FOLLOWS QUITE SMALL DOSES OF HISTAMINE, YET ANIMAL MAY SURVIVE A HUNDRED LETHAL DOSES OF HISTAMINE IF GIVEN AN H1-BLOCKING DRUG. IN SAME SPECIES, H1 ANTAGONISTS OFFER STRIKING PROTECTION AGAINST ANAPHYLACTIC BRONCHOSPASM, BUT THIS IS NOT SO IN MAN... /H1-RECEPTOR ANTAGONISTS/

Natural Pollution Sources · 3 items

OCCURS WIDELY IN NATURE AS A RESULT OF PUTREFACTIVE PROCESSES.

.../HISTAMINE/ IS A NATURAL CONSTITUENT OF BODY. ... LIBERATED FROM CELLS OF SKIN BY INJURIOUS STIMULI.../&/ INVOLVED IN MANY... DIVERSE PHYSIOLOGICAL PROCESSES...HISTAMINE RECEPTORS...FALL INTO 2 BROAD CLASSES: H1 & H2...

Chemistry & industry

Pharmacology

Bionecessity...ENDOGENOUS HISTAMINE IS FINAL COMMON MEDIATOR OF GASTRIC SECRETORY RESPONSES.../IT IS SUPPOSED/ TO BE INVOLVED IN TISSUE GROWTH & REPAIR, IN REGULATION OF MICROCIRCULATION, & IN FUNCTIONING OF CNS...
PharmacodynamicsHistamine stimulates gastric gland secretion, causing an increased secretion of gastric juice of high acidity. This action is probably due mainly to a direct action on parietal and chief gland cells.
Mechanism of Action · 6 items

Histamine acts directly on the blood vessels to dilate arteries and capillaries; this action is mediated by both H 1- and H 2-receptors. Capillary dilatation may produce flushing of the face, a decrease in systemic blood pressure, and gastric gland secretion, causing an increased secretion of gastric juice of high acidity. Increased capillary permeability accompanies capillary dilatation, producing an outward passage of plasma protein and fluid into the extracellular spaces, an increase in lymph flow and protein content, and the formation of edema. In addition, histamine has a direct stimulant action on smooth muscle, producing contraction if H 1-receptors are activated, or mostly relaxation if H 2-receptors are activated. Also in humans, the stimulant effect of histamine may cause contraction of the intestinal muscle. However, little effect is noticed on the uterus, bladder, or gallbladder. Histamine has some stimulant effect on duodenal, salivary, pancreatic, bronchial, and lacrimal glands. Histamine also can bind to H3 and H4 receptors which are involved in the CNS/PNS neurotransmitter release and immune system chemotaxis, respectively.

...CONTRACTS MANY SMOOTH MUSCLES, SUCH AS...BRONCHI & GUT, BUT...RELAXES OTHERS...OF FINE BLOOD VESSELS. IT IS...POTENT STIMULUS TO GASTRIC ACID PRODUCTION & ELICITS...OTHER EXOCRINE SECRETIONS. ...BRONCHOCONSTRICTION & CONTRACTION OF GUT...INVOLVE H1 RECEPTORS...GASTRIC SECRETION...INVOLVE ACTIVATION OF H2 RECEPTORS...

...AT CELLULAR LEVEL, MANY RESPONSES TO HISTAMINE ARE CLEARLY ATTRIBUTABLE TO INCR IN MEMBRANE PERMEABILITY THAT ALLOWS COMMON INORG IONS (MAINLY CATIONS) TO FLOW DOWN ELECTROCHEM GRADIENTS & ALTER TRANSMEMBRANE POTENTIAL. IT DOUBTLESS EXPLAINS STIMULANT ACTIONS...OF HISTAMINE ON NERVE ENDINGS OR GANGLION CELLS...

...ESSENTIALLY SIMILAR ACTION /TO THAT AT CELLULAR LEVEL/ APPEARS TO ACCOUNT FOR SECRETION, AT LEAST AS IT OCCURS IN CHROMAFFIN CELLS OF ADRENAL MEDULLA. HERE HISTAMINE...MIMIC PHYSIOLOGICAL SECRETAGOGUE ACH IN DEPOLARIZING THE PLASMALEMMA.

Related reactions

24 records
New reaction record
HRID 57260 reaction equation
HRID 57260As reactantuspto-grants-2016_09
HRID 407319 reaction equation
HRID 407319As reactantuspto-grants-2014_06
HRID 723117 reaction equation
HRID 723117As reactantuspto-grants-2006_11
HRID 726239 reaction equation
HRID 726239As reactantuspto-grants-1998_01
HRID 726240 reaction equation
HRID 726240As reactantuspto-grants-1998_01
HRID 726241 reaction equation
HRID 726241As reactantuspto-grants-1998_01
HRID 744047 reaction equation
HRID 744047As reactantuspto-grants-1996_09
HRID 744048 reaction equation
HRID 744048As reactantuspto-grants-1996_09
Page 1 of 3

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes

9.756

PKA1= 9.68; PKA2= 5.88

Collision Cross Section · 3 items

120.4 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]

120 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

120.4 Ų [M+H]+

Other Experimental Properties · 2 items

DELIQUESCENT

PRISMS FROM ETHANOL; MP: 244-246 °C; FREELY SOL IN WATER, METHANOL /DIHYDROCHLORIDE/

Physicochemical properties

Melting point
83 · 83-84 °C (lit.)
Boiling point
167 °C/0.8 · 167 °C/0.8 mmHg (lit.)
Density
0.9902 · 0.9902 (rough estimate)
refractive index
1.469 · 1.4690 (estimate)
storage temp.
-20 °C · -20°C
solubility
20 mg/ml; · DMSO: 20 mg/ml; Ethanol: 10 mg/ml; PBS (pH 7.2): 10 mg/ml
form
Solid
pka
6.04 · 6.04(at 25℃)
color
White to light yellow
Water Solubility
Soluble in water, alcohol, and hot chloroform.
Merck
13 · 13,4739
BRN
2012 · 2012
Stability
Hygroscopic
InChI
1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)
InChIKey
NTYJJOPFIAHURM-UHFFFAOYSA-N
SMILES
NCCc1c[nH]cn1
LogP
-0.7 · -0.700
CAS DataBase Reference
51 · 51-45-6(CAS DataBase Reference)
EWG's Food Scores
1 · 1
NCI Dictionary of Cancer Terms
histamine
FDA UNII
820484 N8I3 · 820484N8I3
NIST Chemistry Reference
Histamine(51-45-6)
EPA Substance Registry System
Histamine (51-45-6)
UNSPSC Code
85151701 · 85151701
NACRES
77 · NA.77
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
301 · H301-H315-H317-H319-H334-H335
Precautionary statements
280 · P280-P301+P310+P330-P302+P352-P305+P351+P338
target organs
Respiratory system
PPE
95 · dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes
Xn
Risk Statements
22 · 22-36/37/38-42/43
Safety Statements
22 · 22-26-36/37
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
1050000 · MS1050000
F
3 · 3-10-23
TSCA
TSCA listed
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29332900 · 29332900
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralEye · Acute Tox. 3 OralEye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3
Hazardous Substances Data
51 · 51-45-6(Hazardous Substances Data)
Toxicity
50 i.p · LD50 i.p. in mice: 2020 mg/kg (Nagai)
Limited Quantities
5 kg · 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)

HISTAMINE IS WIDELY, IF UNEVENLY, DISTRIBUTED THROUGHOUT ANIMAL KINGDOM & IS PRESENT IN MANY VENOMS, NOXIOUS SECRETIONS, BACTERIA & PLANTS.

Human Toxicity Excerpts · 4 items

OVERDOSAGE WITH HISTAMINE IS RARE, & SYMPTOMS ARE GENERALLY NOT DANGEROUS. HOWEVER, MASSIVE DOSES CAUSE INTENSE HEADACHE, FLUSHING, PROFOUND FALL OF BLOOD PRESSURE, BRONCHOSPASM, DYSPNEA, A METALLIC TASTE, VOMITING & DIARRHEA.

.../EYE EFFECT/ OF AN 8% SOLN OF HISTAMINE HYDROCHLORIDE HAS BEEN DESCRIBED IN CASE OF GIRL WHO SPILLED SOME...ON HER HANDKERCHIEF & CONTAMINATED HER RIGHT EYE... IN 10 MIN CONJUNCTIVAE BECAME HYPEREMIC & LIDS EDEMATOUS, WITHOUT DISCOMFORT. REACTION HAD NEARLY DISAPPEARED IN 5 HR & COMPLETELY GONE NEXT DAY... /HCL SALT/

IN SOME HUMAN GLAUCOMATOUS EYES, APPLICATION OF 3% HISTAMINE HYDROCHLORIDE EYEDROPS HAS BEEN KNOWN TO CAUSE RISE IN OCULAR PRESSURE, PARTICULAR IN CASES OF ACUTE GLAUCOMA. /HCL SALT/

...INJECTED INTRADERMALLY...TRIPLE RESPONSE /FOLLOWS/...RED SPOT...BRIGHTER RED...FLARE...DEVELOPING...MORE SLOWLY, &...LOCALIZED EDEMA...DUE TO LOCAL DILATATION OF MINUTE BLOOD VESSELS /&/...DILATATION OF NEIGHBORING ARTERIOLES.../& EDEMA/ DUE TO DIRECT ACTION...ON WALLS OF...VESSELS TO INCR THEIR PERMEABILITY.

Non-Human Toxicity Excerpts · 2 items

IN MOST EXPTL SUSCEPTIBLE SPECIES (CALVES, SWINE, DUCKS, GUINEA PIGS, CATS, DOGS), IM INJECTIONS OF HISTAMINE IN BEESWAX AT RATE OF 1-4 MG/KG/DAY PRODUCES GASTRIC ULCERS WITHIN 1-6 WK.

EXPT ON EXCISED BEEF CORNEAS HAVE DEMONSTRATED THAT HISTAMINE AT CONCN AS LOW AS 0.000005 MOLAR HAS AN UNUSUAL CAPACITY FOR LOOSENING SUPERFICIAL EPITHELIAL CELLS FROM BASAL CELLS OF CORNEA AFTER SEVERAL HR OF INCUBATION.

Safety data

F
3-10-23
PPE
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
wgk
3
tsca
TSCA listed
rtecs
MS1050000
ridadr
UN 2811 6.1/PG 3
hs_code
29332900
Toxicity
LD50 i.p. in mice: 2020 mg/kg (Nagai)
risk_code
22-36/37/38-42/43
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
hazard_code
Xn
safety_code
22-26-36/37
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
target organs
Respiratory system
Hazard statements
H301-H315-H317-H319-H334-H335
Limited Quantities
5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
Hazard Classifications
Acute Tox. 3 OralEye Irrit. 2Resp. Sens. 1Skin Irrit. 2Skin Sens. 1STOT SE 3
Precautionary statements
P280-P301+P310+P330-P302+P352-P305+P351+P338
Hazardous Substances Data
51-45-6(Hazardous Substances Data)

MODE OF ACTION OF HISTAMINE...TO PRODUCE SMOOTH MUSCLE RELAXATION, INCL VASODILATION, HAS NOT BEEN DEFINED.

CLASSICAL...ANTIHISTAMINES ARE...CAPABLE OF BLOCKING...H1 RECEPTORS ONLY... H2 RECEPTORS...ARE INHIBITED PREFERENTIALLY BY H2-RECEPTORS ANTAGONISTS.

Metabolism/Metabolites · 4 items

Primarily hepatic. Histamine is rapidly metabolized by methylation and oxidation. Methylation involves ring methylation and catalyzation by the enzyme histamine-N-methyltransferase, producing N-methylhistamine, which is mostly converted to N-methyl imidazole acetic acid. 2 to 3% excreted as free histamine, 4 to 8% as N-methylhistamine, 42 to 47% as N-methyl imidazole acetic acid, 9 to 11% as imidazole acetic acid, and 16 to 23% as imidazole acetic acid riboside.

IN MAN THERE ARE 2 MAJOR PATHS OF HISTAMINE METAB. MORE IMPORTANT ONE INVOLVES RING METHYLATION & IS CATALYZED BY...HISTAMINE-N-METHYLTRANSFERASE (IMIDAZOLE-N-METHYLTRANSFERASE, INMT). MOST OF PRODUCT, METHYLHISTAMINE, IS CONVERTED BY MONOAMINE OXIDASE TO METHYL IMIDAZOLE ACETIC ACID (METHYL IMAA).

IN OTHER PATH, HISTAMINE UNDERGOES OXIDATIVE DEAMINATION CATALYZED MAINLY BY DIAMINOXIDASE (DAO), ALSO CALLED "HISTAMINASE"... THE PRODUCTS ARE IMIDAZOLE ACETIC ACID (IMAA) &, EVENTUALLY, ITS RIBOSIDE.

.../MUCH OF VERY LARGE AMT OF HISTAMINE GIVEN ORALLY/ IS CONVERTED BY INTESTINAL BACTERIA TO N-ACETYLHISTAMINE.

MeSH Pharmacological ClassificationDrugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically.
Absorption, Distribution and Excretion · 4 items

Readily absorbed after parenteral administration.

HISTAMINE IS READILY ABSORBED AFTER PARENTERAL INJECTION...

THE VARIOUS METAB, WHICH HAVE LITTLE OR NO PHARMACOLOGICAL ACTIVITY, ARE EXCRETED IN URINE.

HISTAMINE & N-METHYLHISTAMINE ACCUM IN TISSUE DEPOTS.

Tissue LocationsAdipose Tissue
Cellular LocationsExtracellular
Metabolite PathwaysAcrivastine H1-Antihistamine Action

Uses & manufacturing

UsesMEDICATION
Methods of ManufacturingPRODUCED FROM HISTIDINE BY PNEUMOCOCCI OR B COLI: LEVY-BRUHL, UNGAR, ANN INST PASTEUR 61, 828 (1938).
Formulations/Preparations · 1 item

HISTAMINE PHOSPHATE, USP, & HISTAMINE DIHYDROCHLORIDE... HISTAMINE PHOSPHATE INJECTION, USP, CONTAINS 1 MG OF SALT (0.36 MG OF HISTAMINE BASE) IN 1 ML. OTHER AVAIL PREPN CONTAIN 0.275 & 2.75 MG OF HISTAMINE PHOSPHATE IN 1 ML (0.1 & 1 MG OF HISTAMINE BASE IN 1 ML), & ARE PACKAGED IN 1- OR 5-ML AMPULES.

General Manufacturing Information1H-Imidazole-5-ethanamine: ACTIVE
Applications · 4 items

HistoryHistamine is an important protein involved in many allergic reactions. Allergies are caused by an immune response to a normally innocuous substance (i.e. pollen, dust) that comes in contact with lymphocytes specific for that substance, or antigen. The history of histamine and the development of antihistamines have been reviewed in [Drugs of Today (1986) and the Journal of Allergy & Clinical Immunology]. Histamine was the first to be characterized of a series of biogenic amines that are released in the inflammatory process. As early as 1910, it was shown that histamine caused constriction of isolated guinea pig ileum and, subsequently, it was found that histamine induced a shock-like syndrome. In 1927 the presence of histamine in normal tissues was demonstrated. Attempts to reduce histamine manifestations led to the report, in 1933, that certain phenolic ethers inhibited histamine action. Toxicity precluded clinical use. In 1942 phenbenzamine (Antergan), C17H22N2, was the first antihistamine to be successfully used in humans. In 1966, the name H1 was proposed for receptors blocked by the at that time known antihistamines. It was also speculated that the other actions of histamine were likely to be mediated by other histamine receptors. The existence of the H2 receptor was accepted in 1972 and the H3 receptor was recognized in rat brain in 1983. H3 receptors in the brain appear to be involved in the feedback control of both histamine synthesis and release, whereas release of various other neurotransmitters, eg, serotinin (5-HT), dopamine, noradrenaline, and acetylcholine, is also modulated. H3 receptor effects have also been demonstrated in various peripheral tissues and H3 agonists and antagonists are undergoing intensive study for therapeutic applications.

UsesHistamine inhibits the synthesis of IL-2 and γ-IFN in peripheral blood mononuclear cells and lipopolysaccharide-induced synthesis of TNF-α in monocytes via H2receptor activation. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.

UsesH1&2 agonist, edema induction, gastric secretion stimulant

General DescriptionHistamine is a neurotransmitter produced by neurons of the posterior hypothalamus. In the brain, histamine is predominantly present in the gray matter.

Upstream & downstream products

Upstream raw materials

L-HistidineBenzoyl chlorideSulfuric acid

Downstream products

DL-HistidineL-Histidine4-pyridin-2-yl-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridine(SALTDATA: H2O)

Additional notes

DefinitionChEBI: A member of the class of imidazoles that is 1H-imidazole substituted at position C-4 by a 2-aminoethyl group.